[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
February 2017

Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy

Author Affiliations
  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
JAMA Cardiol. 2017;2(2):123-124. doi:10.1001/jamacardio.2016.5177

Combination antiretroviral therapy (ART) has affected the lives of human immunodeficiency virus (HIV)–infected individuals who have access to treatment and continues to narrow the gap in life expectancy between persons with HIV and the general population. Unfortunately, concomitant with this favorable outcome, noninfectious causes of morbidity and mortality, particularly cardiovascular disease (CVD), have had a disproportionately negative affect on ART-treated individuals with HIV, creating a “double jeopardy” phenomenon.

×